Genocea Biosciences, Inc. (NASDAQ:GNCA) has scheduled a conference call for 23rd July 2020 at 8:30 AM Eastern Time to announce its 2Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.genocea.com
Earnings Expectation
Genocea Biosciences, Inc. is expected to report second quarter earnings results, before market open, on Thursday 23rd July 2020. Analysts polled by Thomson Reuters anticipate second quarter loss of $ 0.4 per share. Looking ahead, the full year loss are expected at $ 1.6 per share.
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, to recall a patients pre-existing CD4+ and CD8+ T cell immune responses to tumor to identify neoantigens and antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. Its lead immuno-oncology program is GEN-009, an adjuvanted neoantigen peptide vaccine candidate, which is in the phase 1/2a clinical trial, designed to direct a patients immune system to attack tumor.
